Hillsdale Investment Management Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,514,429
-38.3%
37,237
-26.5%
0.14%
-33.8%
Q1 2023$2,452,856
-34.7%
50,637
-48.5%
0.21%
-33.8%
Q4 2022$3,753,523
-25.5%
98,337
-2.0%
0.32%
-30.3%
Q3 2022$5,037,000
+6357.7%
100,337
+4262.5%
0.46%
+4450.0%
Q2 2018$78,0002,3000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders